Format

Send to

Choose Destination
Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7.

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Author information

1
University of Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.
2
Lewis Katz School of Medicine at, Temple University, Philadelphia, Pennsylvania.
3
New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York.
4
University of Texas Health Science Center, San Antonio, Texas.
5
South Texas Veterans Health Care System, San Antonio, Texas.
6
National Heart and Lung Institute, Imperial College, London, United Kingdom.
7
McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
8
Brigham and Women's Hospital, Boston, Massachusetts.
9
State Key Lab for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
10
University of Leuven, Leuven, Belgium.
11
University of Modena and Reggio Emilia, Modena, Italy.
12
Faculty of Medicine, Flinders University, Bedford Park, South Australia, Australia.
13
Royal Devon and Exeter Hospital, Exeter, United Kingdom.
14
Universidad de la República, Hospital Maciel, Montevideo, Uruguay.
15
Hokkaido University School of Medicine, Sapporo, Japan.
16
Hôpital Cochin (Assistance Publique-Hôpitaux de Paris), University Paris Descartes, Paris, France.
17
Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain.
18
St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
19
University of Manchester, Manchester, United Kingdom.
20
University Hospital, Birmingham, United Kingdom.
21
Hospital Clínic, Universitat de Barcelona, Centro de Investigación Biomé dica en Red de Enfermedade Respiratorias, Barcelona, Spain.

Abstract

This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.

KEYWORDS:

COPD diagnosis; COPD management; COPD prevention; chronic obstructive pulmonary disease

PMID:
28150362
DOI:
10.1111/resp.13012
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center